Cathepsin B - Pipeline Review, H2 2020 - PowerPoint PPT Presentation

About This Presentation
Title:

Cathepsin B - Pipeline Review, H2 2020

Description:

Cathepsin B (APP Secretase or Cathepsin B1 or CTSB or EC 3.4.22.1) pipeline Target constitutes close to 8 molecules. Out of which approximately 6 molecules are developed by companies and remaining by the universities/institutes. The latest report Cathepsin B - Pipeline Review, H2 2020, outlays comprehensive information on the Cathepsin B (APP Secretase or Cathepsin B1 or CTSB or EC 3.4.22.1) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. – PowerPoint PPT presentation

Number of Views:3
Slides: 9
Provided by: kiran1998
Tags:

less

Transcript and Presenter's Notes

Title: Cathepsin B - Pipeline Review, H2 2020


1
Cathepsin B - Pipeline Review, H2
2020
Published on 23 nov 2020
2
Report Overview
Cathepsin B (APP Secretase or Cathepsin B1 or
CTSB or EC 3.4.22.1) pipeline Target constitutes
close to 8 molecules. Out of which approximately
6 molecules are developed by companies and
remaining by the universities/institutes. The
latest report Cathepsin B - Pipeline Review, H2
2020, outlays comprehensive information on the
Cathepsin B (APP Secretase or Cathepsin B1 or
CTSB or EC 3.4.22.1) targeted therapeutics,
complete with analysis by indications, stage of
development, mechanism of action (MoA), route of
administration (RoA) and molecule type.
3
Key Benefits for Cathepsin B - Pipeline Review,
H2
  • The report provides a snapshot of the global
    therapeutic landscape for Cathepsin B (APP
    Secretase or Cathepsin B1 or CTSB or EC 3.4.22.1)
  • The report reviews Cathepsin B (APP Secretase or
    Cathepsin B1 or CTSB or EC 3.4.22.1) targeted
    therapeutics under development by companies and
    universities/research institutes based on
    information derived from company and
    industry-specific sources
  •  The report covers pipeline products based on
    various stages of development ranging from
    pre-registration till discovery and undisclosed
    stages
  • The report features descriptive drug profiles for
    the pipeline products which includes, product
    description, descriptive MoA, RD brief,
    licensing and collaboration details other
    developmental activities
  • The report reviews key players involved in
    Cathepsin B (APP Secretase or Cathepsin B1 or
    CTSB or EC 3.4.22.1) targeted therapeutics and
    enlists all their major and minor projects

4
Market Size
Download Free Sample
Expected to reach xx million USD by the end of
Forecast year
2026
2020
Base year
CAGR xx (2020 - 2026)
91-8087042414 (Asia) (1) 646 781 7170
(Int'l) help_at_grandresearchstore.com
5
By Region
United States
Europe
China
Rest of the world
Japan
91-8087042414 (Asia) (1) 646 781 7170
(Int'l) help_at_grandresearchstore.com
6
Application
  •  Gain strategically significant competitor
    information, analysis, and insights to formulate
    effective RD strategies
  •  Identify emerging players with potentially
    strong product portfolio and create effective
    counter-strategies to gain competitive advantage
  • Identify and understand the targeted therapy
    areas and indications for Cathepsin B (APP
    Secretase or Cathepsin B1 or CTSB or EC
    3.4.22.1)Identify the use of drugs for target
    identification and drug repurposing
  •  Identify potential new clients or partners in
    the target demographic
  •  Develop strategic initiatives by understanding
    the focus areas of leading companies
  •  Plan mergers and acquisitions effectively by
    identifying key players and it?s most promising
    pipeline therapeutics

7
Download Free Sample
Get in touch
Call 91-8087042414 (Asia) (1) 646 781 7170
(Int'l) E-mail help_at_grandresearchstore.com
Sample includes
  • Table Of Contents
  • List of Tables Figures
  • Charts
  • Research Methodology

Follow Us
8
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com